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Abstract 
Background: The mortality of critically ill patients with COVID-19 is high, particularly among those receiving 
mechanical ventilation (MV). Despite the high number of patients treated worldwide, data on respiratory mechanics 
are currently scarce and the optimal setting of MV remains to be defined. This scoping review aims to provide an over-
view of available data about respiratory mechanics, gas exchange and MV settings in patients admitted to intensive 
care units (ICUs) for COVID-19-associated acute respiratory failure, and to identify knowledge gaps.
Main text: PubMed, EMBASE, and MEDLINE databases were searched from inception to October 30, 2020 for studies 
providing at least one ventilatory parameter collected within 24 h from the ICU admission. The quality of the studies 
was independently assessed using the Newcastle–Ottawa Quality Assessment Form for Cohort Studies. A total of 26 
studies were included for a total of 14,075 patients. At ICU admission, positive end expiratory pressure (PEEP) values 
ranged from 9 to 16.5 cm of water  (cmH2O), suggesting that high levels of PEEP were commonly used for setting MV 
for these patients. Patients with COVID-19 are severely hypoxemic at ICU admission and show a median ratio of partial 
pressure of arterial oxygen to fraction of inspired oxygen  (PaO2/FiO2) ranging from 102 to 198 mmHg. Static respira-
tory system compliance (Crs) values at ICU admission were highly heterogenous, ranging between 24 and 49 ml/
cmH2O. Prone positioning and neuromuscular blocking agents were widely used, ranging from 17 to 81 and 22 to 
88%, respectively; both rates were higher than previously reported in patients with “classical” acute respiratory distress 
syndrome (ARDS).
Conclusions: Available data show that, in mechanically ventilated patients with COVID-19, respiratory mechanics 
and MV settings within 24 h from ICU admission are heterogeneous but similar to those reported for “classical” ARDS. 
However, to date, complete data regarding mechanical properties of respiratory system, optimal setting of MV and 
the role of rescue treatments for refractory hypoxemia are still lacking in the medical literature.
Keywords: Coronavirus disease 2019, Acute respiratory distress syndrome, Mechanical ventilation, Intensive care 
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Introduction
Mechanical organ support has always been a mainstay 
of intensive care and especially the use of mechani-
cal ventilation. Among the more than 70 million peo-
ple infected worldwide with SARS-CoV-2, many have 
required mechanical ventilation [1, 2]. Questions are 
being asked regarding the “correct” mode of ventilation 
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for these patients and to date no literature review has 
been published on the topic.
Approximately one in ten patients with SARS-
CoV-2 becomes symptomatic [3]. Although hospi-
tal and Intensive Care Unit (ICU) admission rates are 
highly dependent on resource availability, most studies 
from Europe and North America report that 10–20% 
(depending on age) of the patients admitted to hospital 
undergo some form of mechanical ventilatory support 
due to acute hypoxemic respiratory failure, either in the 
ward or in the ICU [4, 5]. Overall, between one-fourth 
and one-third of hospitalized patients will ultimately be 
admitted to the ICU [6, 7].
The mortality of patients with critical coronavirus 
disease 2019 (COVID-19) is strikingly high, ranging 
between 15 [8] and 74% [9], particularly when inva-
sive mechanical ventilation (IMV) has been required. 
Consequently, questions have been raised regarding 
the relationship between various aspects of mechanical 
ventilation and patient outcomes in this scenario. One 
of the pinnacles of intensive care achievements in the 
last two decades has been the recognition that inappro-
priate setting of mechanical ventilation is a major con-
tributor to lung damage (so called ventilator-induced 
lung injury (VILI)) in patients with “classical” acute res-
piratory distress syndrome (ARDS) [10–14]. However, 
there is ongoing discussion regarding the relevance of 
this insight to the outcomes of patients with SARS-
CoV-2. The first step required to resolve this question is 
to summarize the currently available data. This scoping 
review aimed to map the existing information regard-
ing the respiratory mechanics, mechanical ventilation 
settings and parameters of gas exchange in critically 
ill patients undergoing invasive mechanical ventilation 
(IMV) for treatment of severe COVID 19 and to iden-
tify knowledge gaps.
Methods
The review was prospectively registered in the Open Sci-
ence Framework (OSF) (August 18, 2020; osf.io/8grfc) 
and was conducted in accordance with the Preferred 
Reporting Items for Systematic reviews and Meta-Anal-
yses extension for Scoping Reviews (PRISMA-ScR) [15]. 
The filled PRISMA-ScR checklist is provided in Addi-
tional file  1. We aimed to study respiratory mechan-
ics, ventilation settings and parameters of gas exchange 
reported in adult critically ill patients with COVID-19 
undergoing invasive mechanical ventilation in ICUs. We 
excluded studies reporting data on children and on adult 
patients undergoing non-invasive ventilation. The inclu-
sion and exclusion criteria are summarized in Table  S3 
(Additional file 2).
Search strategy
Two authors (AC, EC) developed the search strategy, 
which is reported in full in Additional file  2. PubMed, 
EMBASE, and MEDLINE databases were searched from 
inception to October 30, 2020 for English-only articles. 
Following the initial search, three of the reviewers (EC, 
GF, AZ) independently screened the titles and abstracts 
of the retrieved papers to identify those warranting full 
review. Studies reporting duplicate patient populations 
were excluded. Two of the authors (EC, GF) accessed 
the selected papers for full-text review and evaluated 
them for inclusion. We included only original articles 
(non-randomized studies, excluding case reports) report-
ing at least one parameter pertinent to our study ques-
tion (i.e. respiratory mechanics, ventilation settings, gas 
exchange at ICU admission or within the first day of ICU 
stay). This time frame was selected based on the under-
standing that most critically ill patients undergo routine 
baseline assessments at admission. Articles not report-
ing any baseline ventilation parameter and those includ-
ing only patients treated with extracorporeal membrane 
oxygenation (ECMO) were excluded at this stage. The 
final selection included only studies reporting at least 
one ventilatory parameter as detailed below (see “data 
extraction”).
Quality of the studies
Two authors (AC, EC) independently assessed the qual-
ity of the studies using the Newcastle–Ottawa Quality 
Assessment Form for Cohort Studies [16]. A third author 
(GG) resolved discrepancies at any stage.
Data extraction
We extracted the data presented on each of the follow-
ing respiratory parameters from the included papers: 
positive end-expiratory pressure (PEEP), Tidal Volume 
in relation to predicted body weight (TV/Pbw), plateau 
pressure (Pplat), driving pressure (ΔP), static compli-
ance of the respiratory system (Crs), respiratory rate (RR) 
and mechanical power. As noted above, only the baseline 
measurements, (i.e. those recorded within the first 24 h 
of ICU stay) were charted. We also collected data on gas 
exchange parameters including partial pressure of arterial 
oxygen  (PaO2), ratio of partial pressure of arterial oxygen 
to fraction of inspired oxygen  (PaO2/FiO2), partial pres-
sure of arterial carbon dioxide  (PaCO2), and use of rescue 
therapies (neuromuscular blocking agents, prone posi-
tioning, inhaled pulmonary vasodilators, extracorporeal 
membrane oxygenation) for refractory hypoxemia when 
available. All data were extracted by one author (EC), 
using a standardized Excel form (Microsoft Excel™ Ver-
sion 2016 for Windows). A second author (GF) verified 
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and validated the charted data. In most studies the data 
were reported as medians with their interquartile ranges 
(IQRs), while in others they were reported as means with 
their standard deviations (SDs). For the purpose of this 
review we report categorical variables as counts and per-
centages, and continuous data as means (± SDs) or medi-
ans (± IQRs) as presented in the original reports.
Results
The search strategy initially identified 6460 potentially 
relevant papers. After removal of duplicates, the titles 
and abstracts of 6458 papers were screened of which 
6401 were excluded and 57 were selected for full text 
review. Among the 57 papers undergoing full review, 31 
papers were subsequently excluded—21 for not reporting 
any of the required parameters, 8 for reporting relevant 
data outside of the predetermined time frame and 2 for 
describing only patients treated with ECMO.
The final selection included 26 studies: 4 multicenter 
prospective cohort studies [17–20], 6 multicenter retro-
spective cohort studies [8, 21–25], 1 single center pro-
spective cohort study [26], 1 multicenter prospective case 
series [27], 2 multicenter retrospective case series [28, 
29], 4 single center prospective case series [30–33] and 
8 single center retrospective case series [34–41] (Fig. 1).
Table  S1 (see Additional file  2) summarizes the main 
characteristics of the included studies. Most of the stud-
ies described patients receiving mechanical ventilation in 
either North America or Europe (25/26), and one study 
was conducted in China. As shown in Table 1, the num-
ber of respiratory mechanics and ventilation settings 
parameters provided by the studies was very heteroge-
neous. Two of the largest studies [21, 22] reported only 
PEEP values, while other studies provided a more com-
plete set of data at ICU admission (Fig. 2).
Table S2 (see Additional file 2) reports the quality of the 
included studies as assessed using the Newcastle–Ottawa 
Fig. 1 PRISMA flow diagram of included studies
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Quality Assessment tool and shows that all studies except 
one are of poor quality.
Respiratory mechanics and ventilation settings 
within the first 24 hours of ICU stay
Mode of ventilation: The mode of ventilation was 
reported in 5/26 studies. In four of them the choice was 
volume-controlled ventilation [18, 26, 31, 36] while in 
the fifth study pressure-controlled ventilation was used 
in 52% and volume-controlled ventilation in 19% of the 
cases [23].
Tidal volume: TV was reported in 13/26 studies. The 
values of TV per predicted body weight varied from 5.6 
to 7.5 ml/Kg [38, 40, 41].
Respiratory rate: RR was reported in 10/26 studies and 
ranged from 20 to 33 breaths/min [18, 23, 32, 41].
PEEP: All but three of the studies reported PEEP with 
median values that ranged from a minimum of 9  cmH2O 
[41] to a maximum of 16.5  cmH2O [32]; only two of the 
studies reported a median value lower than 10  cmH2O.
Plateau pressure: Plateau pressures, which were 
reported in 18/26 studies ranged from 20.5 to 31  cmH2O 
[27, 34].
Driving pressure: Driving pressures were reported in 
17/26 studies and ranged from 9.5 to 15  cmH2O [20, 32, 
39].
Static compliance: Static respiratory system compli-
ance was reported in 20/26 studies. The values reported 
showed wide variability, ranging from 24 [27] to 49 ml/
cmH2O [34, 39] (Fig. 3), although the range was slightly 
more narrow, from 27 to 41  ml/cmH2O, in studies that 
included more than 100 patients [18, 20].
Mechanical Power: Mechanical Power was reported in 
only 4/26 studies. The median values reported ranged 
from 26.5 [17] to 16.8 J/min [18].
Gas exchange within the first 24 hours of ICU stay
PaO2 values were reported in only 7/26 studies. The 
reported values ranged from 73 to 95 mmHg [22, 38].
PaCO2 values were reported in 12/26 studies and var-
ied between 40 and 57 mmHg [17, 33].
FiO2 was reported in 19/26 studies, and ranged from 45 
to 100% [20, 32].
PaO2/FiO2 was reported in 24/26 studies. All patients 
had acute hypoxemic respiratory failure, with a median 
 PaO2/FiO2 that ranged from 102 to 198 mmHg [32, 40].
When considering only studies with more than 100 
patients, median values of the  PaO2/FiO2 ratio and 
 PaCO2 ranged from 103 to 180 mmHg [8, 26] and 40 to 
46 mmHg [17, 18], respectively.
Patient management
Table 2 summarizes other aspects of respiratory patient 
management during ICU stay, including the use of rescue 
therapies for ARDS (data from 16/26 papers), and clinical 
outcomes (reported in 20/26 papers).
Prone position was used in up to 81% [37] of the 
patients and neuromuscular blocking agents were admin-
istered to up to 88% [17] of the patients. Higher propor-
tions of patients received these two rescue therapies in 
European studies relative to North American studies.
Treatment with pulmonary vasodilators (usually 
inhaled nitric oxide) was reported in only 10 papers, and 
these treatments were provided to between 11 and 35% 
of the patients [8, 20, 21, 24, 41].
Use of Extracorporeal Membrane Oxygenation as res-
cue therapy for refractory hypoxemia ranged from 1 to 
19% [23, 37] among the studies.
Discussion
This review highlights the paucity of data regarding one 
of the greatest challenges in managing patients with 
COVID-19 – mechanical ventilation. Extrapolation from 
the number of patients with confirmed disease suggests 
that between one quarter to half a million COVID-19 
patients have already undergone mechanical ventilation 
worldwide. Since the pandemic outbreak, more than 
80,000 papers have been published regarding COVID-
19[42]. Several observational studies have described very 
Fig. 2 Network geometry shows nodes as reported respiratory 
mechanic parameters or ventilator settings and studies reporting a 
couple of parameters as lines. The size of the nodes is proportional to 
the number of patients with that reported parameter. The thickness 
of the connecting line is proportional tothe number of studies that 
report both the connected parameter. Abbreviations: PEEP, positive 
end-expiratory pressure;  FiO2, fraction of inspired oxygen; Crs, 
compliance of the respiratory system; Pplat, plateau pressure; RR, 
respiratory rate; ΔP, driving pressure; TV, tidal volume
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large populations of critically ill patients with COVID-19 
but these provided little to no information on respiratory 
mechanics or management of mechanical ventilation [6, 
9, 43]. Our search of the literature revealed only 26 stud-
ies for a total of 14,075 patients that reported the res-
piratory mechanics, ventilation settings and parameters 
of gas exchange in critically ill patients with COVID-19 
undergoing IMV. We also identified three review papers 
that discussed mechanical ventilation of COVID-19 
patients [44–46]. However, these reviews did not describe 
precise ventilator settings or provide measurements of 
respiratory mechanics.
Oxygenation, or more specifically the  PaO2/FiO2 ratio, 
was described in all but two of the papers. Although 
PEEP was reported in most studies, only two described 
how this parameter was selected, with one study titrating 
on oxygenation [37] and the other using the PEEP/FiO2 
table [28]. In contrast, only a handful of studies described 
mechanics and ventilation parameters – respiratory sys-
tem compliance, driving pressures, plateau pressures, 
 PaCO2, TV and RR were inconsistently reported. Those 
values that have been reported raise important questions 
on the validity of our early prior assumptions regarding 
these disease characteristics.
In the early stage of the pandemic and based on physi-
ological data collected from only 16 subjects [47], it was 
postulated that there are two distinct clinical types of 
COVID-19 respiratory disease, differing in static res-
piratory system compliance, intrapulmonary shunt frac-
tion and recruitability [48]. It was also suggested that the 
mechanical ventilation of patients classified to these two 
clinical types of disease should also differ; those with stiff 
lungs should be ventilated in accordance with the recom-
mendations for ARDS, and those with compliant lungs 
may be ventilated with higher tidal volumes (7–9 ml/kg 
ideal body weight) and lower PEEP (< 10   cmH2O) than 
recommended [49]. Subsequent studies conducted in 
larger patient populations did not confirm this observa-
tion [17, 19, 20, 23, 26]. Our review of the available litera-
ture, limited as it is to pooled data from multiple studies 
with different methodologies, also does not support the 
existence of a clinical dichotomy. Instead, there appears 
to be a broad-range continuum. In particular, the median 
values of Crs ranged from 24 to 49  ml/cmH2O [27, 34, 
39], narrowing only slightly in studies that included 
more than 100 patients. In addition, when only studies 
that reported the median (IQR) Crs are considered, only 
21% of the 75th percentile values are higher than 50 ml/
a b
c d
Fig. 3 Multi-panel figure showing the distribution of the reported median, 25th and 75th percentile of a: plateau pressure; b: Tidal Volume/Pbw; 
c: PEEP; d: respiratory system compliance. Each circle represents a single study and its size is proportional to the number of included patients. 
(abbreviation: PEEP positive end expiratory pressure; TV/pbw Tidal Volume/predicted body weight)
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cmH2O. These values are comparable to those reported 
in the LUNG SAFE study, where Crs varied from 37 (28–
53) ml/cmH2O in mild ARDS to 28 (22–39) ml/cmH2O 
in severe ARDS [50].
The settings used for mechanical ventilation were 
relatively consistent across the studies and generally fol-
lowed evidence-based recommendations for lung protec-
tive ventilation [51]. Plateau and driving pressure were 
largely within the protective limits, with median Pplat 
values that ranged from 20.5 to 31  cmH2O [27, 34] and 
median driving pressures from 9.5 to 15  cmH2O [20, 32, 
39]. Median tidal volume almost never exceeded 8 ml/Kg 
and in most studies it was set around the recommended 
value of 6  ml/kg PBW [51]. However, since  PaCO2 and 
RR were inconsistently reported it remains unclear how 
these were modified to accommodate the required vol-
ume and pressure limits in the subset of patients with 
reduced lung compliance.
In all but two studies, the median PEEP level 
was ≥ 10  cmH2O. These values are somewhat higher 
than those reported in the LUNG SAFE study (8.4 
 cmH2O) [50]. COVID-19 patients are often severely 
hypoxemic at presentation (baseline  PaO2/FiO2 fre-
quently < 150  mmHg) which may explain the appli-
cation of these levels of PEEP and the higher rates of 
prone positioning and neuromuscular blocking agents 
compared to “classical” ARDS patients (respectively 
ranging from 17 to 81 [20, 37] and 22 to 88% [17, 24] 
versus 7.9% and 21.7% in the LUNG SAFE study [50]). 
However, in the absence of detailed information regard-
ing the exact distribution of the  PaO2/FiO2 measure-
ments and their relationship with PEEP all comparisons 
may be moot.
The principal aim of scoping reviews is to highlight 
knowledge gaps and, in this regard, the current review 
provides justification for additional studies of mechanical 
Table 2 Patient management strategies and outcomes in the included studies






























61/1859 (3.3%) 875/2215 
(39.5%)
Grasselli [22] 2929/3355 
(87%)
64/3857 (1.7%) 1769/3988 
(44%)
91/3988 (2.3%) 2049/3988 
(51%)
Ferrando [19] 742/742 
(100%)
536/742 (72%) 564/735 (77%) 21/738 (2.8%) 241/742 (32%) 100 (13%) 401/742 (54%)
Botta [23] 553/553
(100%)
183/487 (38%) 283/530 (53%) 2/553 (< 1%) 203/530 (38%)




Schenck [26] 267/267 
(100%)
161/267 (60%) 108/267 (40%) 49/267 (18%) 140/267 (52%)
Cummings 
[20]
203/257 (79%) 51/203 (25%) 35/203 (17%) 22/203 (11%) 6/203 (3%) 101/257 (39%)
Roedl [24] 167/223 (75%) 37/167 (22%) 108/167 (64%) 19/167 (11%) 20/223 (9%) 78/223 (35%)
Auld [25] 165/217 (76%) 22/165 (13%) 4/165 (2%) 62/217 (29%) 8/217 (4%) 147/217 (68%)
Mitra [8] 74/117 (63%) 50/74 (68%) 21/74 (28%) 8/74 (11%) 3/74 (4%) 18/117 (15%) 12/117 (10%) 87/117 (74%)
Pandya [35] 75/75 (100%) 37/75 (49%)
Cavayas [41] 43/75
(56%)
16/43 (37%) 11/43 (26%) 15/43 (35%) 1 (2%) 17/75 (23%) 58/75 (77%)
Zangrillo [36] 73/73 (100%) 53/70 (76%) 55/72 (76%) 5/73 (7%) 17/73 (23%) 33/73 (45%) 23/73 (32%)
Ziehr [28] 66/66 (100%) 28/66 (42%) 31/66 (47%) 18/66 (27%) 3/66 (5%) 11/66 (17%) 5/66 (8%) 50/66 (76%)
Sinha [27] 39/39 (100%) 17/39 (44%)
Laverdure [37] 36/36 (100%) 29/36 (81%) 9/39 (25%) 7 (19%) 4/36 (11%) 7/36 (19%) 25/36 (69%)
Bhatraju [29] 18/24 (75%) 7/18 (39%) 5/18 (28%) 5/18 (28%) 0 12/24 (50%)
Pedersen [38] 17/17 (100%) 5/17 (29%) 0 7/17 (41%) 6/17 (35%) 4/17 (24%)
Liu X [40] 8/8 (100%) 0/8 3/8 (37%) 5/8 (63%)
LUNGSAFE [50] 21.7% 7.9% 7.7% 3.2% 35.3%
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ventilation of critically ill COVID-19 patients. We found 
no studies comparing different ventilation strategies (e.g. 
different approaches to PEEP titration) and few studies 
(5/26) that reported the mode of ventilation [18, 23, 26, 
31, 36]. Only 5/26 studies reported mechanical power 
which is a critical parameter [17, 18, 23, 41]. Such infor-
mation could prove extremely important for guiding 
the mechanical ventilation of patients with COVID-19. 
Only a handful of small studies, performed in highly 
selected patient populations, attempted to character-
ize the mechanical properties of the respiratory system 
in COVID-19 patients undergoing invasive mechani-
cal ventilation using advanced monitoring techniques 
(e.g. esophageal pressure monitoring, electrical imped-
ance tomography) [30, 52, 53]. The pathophysiological 
mechanisms underlying the severe hypoxemia observed 
in patients with COVID 19 have not been elucidated; in 
particular, the respective contributions of ventilation-
perfusion mismatch, and the dysregulation of hypoxic 
vasoconstriction and occlusion of the pulmonary vas-
cular bed require further study. Finally, the role of res-
cue therapies, such as prone positioning and ECMO, in 
the treatment of refractory hypoxemia, and their actual 
impact on patient outcomes remain unclear; however 
the higher rate of prone positioning compared to LUNG 
SAFE and a better adherence to protective ventilation 
strategies are substantial findings clearly pointed out by 
the present review.
Our review has several strengths. To the best of our 
knowledge, this is the first scoping review on respiratory 
mechanics and ventilation settings in critically ill patients 
with COVID-19. The methodology of a scoping review 
enables comprehensive mapping of current knowledge 
and identification of knowledge gaps in the existing lit-
erature. We used predefined inclusion and exclusion cri-
teria and adhered to the PRISMA ScR checklist to ensure 
consistency in reviewer agreement, data extraction and 
synthesis.
We also acknowledge some significant limitations of 
our work. A scoping review is only as good as the stud-
ies it identifies. Most of the studies included in the pre-
sent review were retrospective, and the few conducted 
prospectively were observational. The studies are highly 
heterogeneous with regard to the number of vari-
ables analyzed and the quality of the data they present. 
For example, two of the studies with the largest sam-
ples reported only the value of PEEP [21, 22]. None of 
the studies evaluated how spontaneous breathing may 
have influenced respiratory mechanics measurements, 
however, since the majority of the patients were para-
lyzed with continuous infusion of NMBA (up to 88%) 
the impact of spontaneous breathing activity should be 
null or extremely limited. The variability in the type and 
quality of data presented and the abundance of miss-
ing data probably reflect the many difficulties encoun-
tered by researchers endeavoring to collect data on 
these complex patients. COVID ICUs were created in 
an impromptu manner. Clinicians workload was over-
whelming; makeshift equipment with no interface with 
the hospital electronic medical records was often placed 
in these units, effectively reducing availability of elec-
tronic documentation. The nursing staff working in such 
units may have had little ICU training, which also limited 
the quality of documentation. Additionally, some of the 
studies we identified were based on manual review of 
medical records, which has inherent limitations [8, 21, 
25]. Quantitative data were sometimes reported as medi-
ans and other times as means. All of these issues make 
study comparisons challenging and preclude the pool-
ing of findings, resulting in an inability to draw definitive 
conclusions.
We also excluded studies reporting respiratory 
mechanics after the first 24  h of ICU admission. This 
approach was used to reduce data heterogeneity and the 
need to account for missing data, but also resulted in a 
lack of information regarding the evolution of the respir-
atory disease. As an example, few studies have evaluated 
the recruitability of COVID-19 patients. These stud-
ies could not be included in this review as their design 
and characteristics did not fulfill the inclusion criteria. 
However, those studies show that the potential for lung 
recruitment in COVID-19 is also highly heterogeneous, 
similar to the range observed in “classical” ARDS patients 
[52–55].
Conclusion
The available literature shows that critically ill COVID-19 
patients requiring invasive ventilation have very hetero-
geneous gas exchange and respiratory mechanics during 
the first 24  h of ICU admission. This finding is remi-
niscent of the characteristics reported in patients with 
ARDS from other causes. Low tidal volumes and levels of 
PEEP equal to or higher than 10  cmH2O are commonly 
used. Prone positioning is more frequently used than in 
other causes of ARDS. We identified significant gaps in 
current knowledge, particularly regarding the mechani-
cal properties of the respiratory system, the relative con-
tribution of different pathophysiological mechanisms 
to the generation of hypoxemia, the optimal settings of 
mechanical ventilation, the potential for lung recruit-
ment, the response to different PEEP levels and the role 
of rescue treatments for refractory hypoxemia. Our 
review highlights the need for a pooled analysis of avail-
able data to further fill these knowledge gaps.
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